GlycoMimetics Inc (NASDAQ:GLYC) has a beta value of 1.64 and has seen 2.77 million shares traded in the recent trading session. The company, currently valued at $16.21M, closed the recent trade at $0.25 per share which meant it gained $0.02 on the day or 10.95% during that session. The GLYC stock price is -696.0% off its 52-week high price of $1.99 and 44.0% above the 52-week low of $0.14. If we look at the company’s 10-day average daily trading volume, we find that it stood at 0.19 million shares traded. The 3-month trading volume is 1.36 million shares.
The consensus among analysts is that GlycoMimetics Inc (GLYC) is Hold stock at the moment, with a recommendation rating of 3.00. 0 analysts rate the stock as a Sell, while 0 rate it as Overweight. 1 out of 1 have rated it as a Hold, with 0 advising it as a Buy. 0 have rated the stock as Underweight. The expected earnings per share for the stock is -0.05.
GlycoMimetics Inc (NASDAQ:GLYC) trade information
Sporting 10.95% in the green today, the stock has traded in the green over the last five days, with the highest price hit on recent trading when the GLYC stock price touched $0.25 or saw a rise of 8.86%. Year-to-date, GlycoMimetics Inc shares have moved 0.92%, while the 5-day performance has seen it change 10.32%. Over the past 30 days, the shares of GlycoMimetics Inc (NASDAQ:GLYC) have changed -4.70%. Short interest in the company has seen 2.46 million shares shorted with days to cover at 9.85.
GlycoMimetics Inc (GLYC) estimates and forecasts
The company’s shares have gained 58.65% over the past 6 months.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was 15.18% over the past 5 years. Earnings growth for 2025 is a modest 96.61% while over the next 5 years, the company’s earnings are expected to increase by 62.95%.
GLYC Dividends
GlycoMimetics Inc is expected to release its next earnings report on 2025-Feb-12 this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
GlycoMimetics Inc (NASDAQ:GLYC)’s Major holders
Insiders own 2.65% of the company shares, while shares held by institutions stand at 47.17% with a share float percentage of 48.46%. Investors are also buoyed by the number of investors in a company, with GlycoMimetics Inc having a total of 47.0 institutions that hold shares in the company. The top two institutional holders are BVF INC/IL with over 9.54 million shares worth more than $2.69 million. As of 2024-06-30, BVF INC/IL held 14.8071% of shares outstanding.
The other major institutional holder is ARTAL GROUP S.A., with the holding of over 8.59 million shares as of 2024-06-30. The firm’s total holdings are worth over $2.42 million and represent 13.3252% of shares outstanding.
Also the top two Mutual Funds that are holding company’s shares are VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund . As of Dec 31, 2024 , the former fund manager holds about 2.98% shares in the company for having 1.93 shares of worth $0.49 million while later fund manager owns 730.6 shares of worth $0.19 million as of Dec 31, 2024 , which makes it owner of about 1.13% of company’s outstanding stock.
